KR100665204B1 - 글리코펩티드 유도체 및 그를 포함하는 약학적 조성물 - Google Patents

글리코펩티드 유도체 및 그를 포함하는 약학적 조성물 Download PDF

Info

Publication number
KR100665204B1
KR100665204B1 KR1020017003918A KR20017003918A KR100665204B1 KR 100665204 B1 KR100665204 B1 KR 100665204B1 KR 1020017003918 A KR1020017003918 A KR 1020017003918A KR 20017003918 A KR20017003918 A KR 20017003918A KR 100665204 B1 KR100665204 B1 KR 100665204B1
Authority
KR
South Korea
Prior art keywords
delete delete
substituted
alkyl
group
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
KR1020017003918A
Other languages
English (en)
Korean (ko)
Other versions
KR20010085857A (ko
Inventor
주디스제이.케빈
파더리폴로스
램버니스엠.티.
레드베터마이클
린셀마틴세링햄
무용키
트랩션게리
양구앙
주얀
Original Assignee
세라밴스 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 세라밴스 인코포레이티드 filed Critical 세라밴스 인코포레이티드
Publication of KR20010085857A publication Critical patent/KR20010085857A/ko
Application granted granted Critical
Publication of KR100665204B1 publication Critical patent/KR100665204B1/ko
Assigned to 세라밴스 바이오파마 안티바이오틱스 아이피, 엘엘씨 reassignment 세라밴스 바이오파마 안티바이오틱스 아이피, 엘엘씨 권리의 전부이전등록 Assignors: 세라밴스 인코포레이티드
Assigned to 큠버랜드 파마슈티컬즈 인코포레이티드 reassignment 큠버랜드 파마슈티컬즈 인코포레이티드 권리의 전부이전등록 Assignors: 세라밴스 바이오파마 안티바이오틱스 아이피, 엘엘씨
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/006—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
    • C07K9/008—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1020017003918A 1998-12-23 1999-12-22 글리코펩티드 유도체 및 그를 포함하는 약학적 조성물 Expired - Lifetime KR100665204B1 (ko)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US11372898P 1998-12-23 1998-12-23
US12931399P 1999-04-14 1999-04-14
US16402499P 1999-11-04 1999-11-04
US16997899P 1999-12-10 1999-12-10
US60/113,728 1999-12-10
US60/129,313 1999-12-10
US60/164,024 1999-12-10
US60/169,978 1999-12-10

Publications (2)

Publication Number Publication Date
KR20010085857A KR20010085857A (ko) 2001-09-07
KR100665204B1 true KR100665204B1 (ko) 2007-01-04

Family

ID=27493926

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020017003918A Expired - Lifetime KR100665204B1 (ko) 1998-12-23 1999-12-22 글리코펩티드 유도체 및 그를 포함하는 약학적 조성물

Country Status (23)

Country Link
US (9) US6392012B1 (https=)
EP (1) EP1140993B1 (https=)
JP (1) JP4362017B2 (https=)
KR (1) KR100665204B1 (https=)
CN (1) CN1249081C (https=)
AT (1) ATE242783T1 (https=)
AU (1) AU768204B2 (https=)
BR (1) BRPI9914221B8 (https=)
CA (1) CA2336445C (https=)
CZ (1) CZ301184B6 (https=)
DE (1) DE69908819T2 (https=)
DK (1) DK1140993T3 (https=)
ES (1) ES2201825T3 (https=)
HK (1) HK1040721B (https=)
HU (1) HU230190B1 (https=)
IL (2) IL140093A0 (https=)
NO (1) NO326066B1 (https=)
NZ (1) NZ508594A (https=)
PL (1) PL198311B1 (https=)
PT (1) PT1140993E (https=)
SI (1) SI1140993T1 (https=)
WO (1) WO2000039156A1 (https=)
ZA (1) ZA200007222B (https=)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69908819T2 (de) * 1998-12-23 2004-05-06 Theravance, Inc., South San Francisco Glycopeptid-derivate und pharmazeutische zusammensetzungen, die sie enthalten
US6699836B2 (en) * 1999-04-02 2004-03-02 The Trustees Of Princeton University Vancomycin analogs
AU4054900A (en) * 1999-04-02 2000-10-23 Advanced Medicine East, Inc. Desleucyl glycopeptide antibiotics and methods of making same
AU2001238020A1 (en) * 2000-02-04 2001-08-14 Advanced Medicine, Inc. Glycopeptide derivatives having antibiotic activity
US6770621B2 (en) 2000-05-02 2004-08-03 Theravance, Inc. Polyacid glycopeptide derivatives
KR100856479B1 (ko) 2000-05-02 2008-09-04 세라밴스 인코포레이티드 환원성 알킬화 방법
JP4870314B2 (ja) 2000-05-02 2012-02-08 セラヴァンス， インコーポレーテッド シクロデキストリンを含むグリコペプチド抗生物質組成物
UA75083C2 (uk) 2000-06-22 2006-03-15 Тераванс, Інк. Похідні глікопептидфосфонатів
US6872804B2 (en) 2000-06-22 2005-03-29 Theravance, Inc. Glycopeptide disulfide and thioester derivatives
WO2001098329A1 (en) * 2000-06-22 2001-12-27 Theravance, Inc. Polyhydroxy glycopeptide derivatives
US6620781B2 (en) * 2000-06-22 2003-09-16 Theravance, Inc. Glycopeptide carboxy-saccharide derivatives
US6905669B2 (en) * 2001-04-24 2005-06-14 Supergen, Inc. Compositions and methods for reestablishing gene transcription through inhibition of DNA methylation and histone deacetylase
TWI312785B (en) 2001-08-24 2009-08-01 Theravance Inc Process for preparing vancomycin derivatives
TWI275594B (en) 2001-08-24 2007-03-11 Theravance Inc Process for preparing vancomycin phosphonate derivatives
ATE322975T1 (de) 2001-09-19 2006-04-15 Procter & Gamble Farbbedruckte mehrschichtstruktur, ein damit hergestellter absorbierender artikel und verfahren zu deren herstellung
TWI335332B (en) 2001-10-12 2011-01-01 Theravance Inc Cross-linked vancomycin-cephalosporin antibiotics
CN101404986B (zh) 2002-05-17 2011-09-28 赛奎拉公司 用于诊断和治疗感染性疾病的组合物和制药方法
US20040033986A1 (en) 2002-05-17 2004-02-19 Protopopova Marina Nikolaevna Anti tubercular drug: compositions and methods
EP1507796B1 (en) * 2002-05-24 2012-05-02 Theravance, Inc. Cross-linked glycopeptide-cephalosporin antibiotics
WO2003106399A2 (en) 2002-06-17 2003-12-24 Theravance, Inc. PROCESS FOR PREPARING N-PROTECTED β-AMINO ALDEHYDE COMPOUNDS
JP4493494B2 (ja) * 2002-07-09 2010-06-30 ファスゲン，インク． ヒトおよび動物における微生物感染症の治療方法
US20060074014A1 (en) * 2002-11-18 2006-04-06 Vicuron Pharmaceuticals Inc. Dalbavancin compositions for treatment of bacterial infections
AU2003299561A1 (en) * 2002-11-18 2004-06-15 Vicuron Pharmaceuticals Inc. Compositions and methods for treating bacterial infections with protein-dalbavancin complexes
ES2335013T3 (es) 2003-05-23 2010-03-18 Theravance, Inc. Antibioticos de glucopeptido-cefalosporina reticulados.
EP1644382B1 (en) * 2003-07-11 2008-03-05 Theravance, Inc. Cross-linked glycopeptide-cephalosporin antibiotics
DE102004055582A1 (de) 2004-11-18 2006-05-24 Bayer Cropscience Ag N-Heterocyclyl-phthalsäurediamide
CA2588285A1 (en) 2004-11-29 2006-06-01 National University Corporation Nagoya University Glycopeptide antibiotic monomer derivatives
US8304597B2 (en) 2004-12-15 2012-11-06 The Procter And Gamble Company Method of using an absorbent article having a functional enhancement indicator
US7368422B2 (en) * 2005-02-28 2008-05-06 Novartis Vaccines And Diagnostics Inc. Semi-synthetic rearranged vancomycin/desmethyl-vancomycin-based glycopeptides with antibiotic activity
US20070185015A1 (en) * 2005-02-28 2007-08-09 Chiron Corporation and North China Pharmaceutical Corporation Semi-synthetic desmethyl-vancomycin-based glycopeptides with antibiotic activity
US7632918B2 (en) * 2005-02-28 2009-12-15 Novartis Vaccines And Diagnostics, Inc. Semi-synthetic glycopeptides with antibiotic activity
JP5192384B2 (ja) 2005-09-22 2013-05-08 メディバス エルエルシー ビス−（α−アミノ）−ジオール−ジエステル含有ポリ（エステルアミド）およびポリ（エステルウレタン）組成物および使用の方法
CA2623239C (en) 2005-09-22 2016-07-12 Medivas, Llc Solid polymer delivery compositions and methods for use thereof
WO2007084507A2 (en) * 2006-01-13 2007-07-26 The Scripps Research Institute [ψ[CH2NH]PG4] GLYCOPEPTIDE ANTIBIOTIC ANALOGS
TW200808818A (en) 2006-05-26 2008-02-16 Shionogi & Co Glycopeptide antibiotic derivatives
CN101959849A (zh) * 2007-12-26 2011-01-26 利德治疗公司 作为抗菌剂的新型半合成糖肽
CN101959900A (zh) 2007-12-26 2011-01-26 盐野义制药株式会社 糖肽类抗生素糖基化衍生物
EP2260060A4 (en) 2008-04-01 2013-01-16 Univ Cornell ORGANIC SOLUBLE CHITOSA SALT AND CHITOSAN DERIVED BIOMATERIALS MANUFACTURED THEREFROM
GB2465863A (en) * 2008-12-05 2010-06-09 Lead Therapeutics Inc Semi-synthetic heptapeptidic glycopeptides for the treatment of bacterial infections
CN101928330B (zh) * 2009-06-26 2013-10-16 上海来益生物药物研究开发中心有限责任公司 一种新的化合物及其应用
US20140171357A1 (en) * 2011-03-24 2014-06-19 Seachaid Pharmaceuticals, Inc. Vancomycin derivatives
CA2904387C (en) 2013-03-15 2021-12-07 Melinta Therapeutics, Inc. Methods of treating infections in overweight and obese patients using antibiotics
IN2013CH04314A (https=) * 2013-09-23 2015-08-28 Jawaharlal Nehru Ct For Advanced Scient Res Jncasr
US20170342110A1 (en) * 2014-12-25 2017-11-30 Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR) Glycopeptides and uses thereof
KR20210094657A (ko) * 2016-01-15 2021-07-29 함부르크대학교 람노실화된 플라보노이드의 제조 방법
CA3012176A1 (en) * 2016-01-28 2017-08-03 ACatechol, Inc. Photo-cleavable primer compositions and methods of use
CN107325159A (zh) * 2016-04-29 2017-11-07 中国科学院上海药物研究所 一类万古霉素衍生物、其制备方法、药物组合物和用途
GB2577420B (en) 2017-05-22 2022-07-06 Insmed Inc Glycopeptide derivative compounds and uses thereof
CN107987131B (zh) * 2017-11-16 2021-03-09 上海来益生物药物研究开发中心有限责任公司 一组具有抗耐药性细菌活性的化合物、其制备方法和应用
CN108409837B (zh) 2018-03-06 2021-09-24 上海来益生物药物研究开发中心有限责任公司 一组具有抗耐药性细菌活性的糖肽类化合物、其制备方法和应用
NL2023883B1 (en) * 2019-09-24 2021-04-26 Univ Leiden Antibiotic compounds
CN111620931B (zh) * 2020-06-12 2021-12-17 苏州博源医疗科技有限公司 万古霉素衍生物及其制备方法和应用
CN114213284B (zh) * 2022-01-04 2023-08-01 丽珠集团福州福兴医药有限公司 (9h-芴-9-基)-癸基(2-氧代乙基)氨基甲酸甲酯及其合成方法
CN121270649A (zh) * 2024-07-03 2026-01-06 烟台新药创制山东省实验室 一类万古霉素衍生物、其制备方法、药物组合物和用途

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4497802A (en) 1983-10-21 1985-02-05 Eli Lilly And Company N-Acyl glycopeptide derivatives
US4914187A (en) 1984-11-13 1990-04-03 Gruppo Lepetit S.P.A Ester derivatives of antibiotic L 17046
GB8428619D0 (en) 1984-11-13 1984-12-19 Lepetit Spa Derivatives of antibiotic l 17046
US4698327A (en) 1985-04-25 1987-10-06 Eli Lilly And Company Novel glycopeptide derivatives
US4639433A (en) 1985-08-14 1987-01-27 Eli Lilly And Company Glycopeptide derivatives
US4643987A (en) 1985-08-14 1987-02-17 Eli Lilly And Company Modified glycopeptides
GB8704847D0 (en) * 1987-03-02 1987-04-08 Lepetit Spa Substituted alkylamides of teicoplanin compounds
FR2632185B1 (fr) * 1988-06-01 1992-05-22 Rhone Poulenc Chimie Silice pour compositions dentifrices compatible notamment avec le zinc
GB8817397D0 (en) 1988-07-21 1988-08-24 Lepetit Spa N15-alkyl & n15 n15-di-alkyl derivatives of teicoplanin antibiotics carrying functional groups on alkyl side chain
US5534420A (en) 1988-07-28 1996-07-09 Eli Lilly And Company Biotransformation of glycopeptide antibiotics
ATE134646T1 (de) * 1988-12-27 1996-03-15 Lepetit Spa C63-amidderivate von 34-de(acetylglucosaminyl)-34-deoxy-teicoplanine
IE64155B1 (en) 1989-03-29 1995-07-12 Lepetit Spa New substituted alkylamide derivatives of teicoplanin
CA2031803C (en) 1989-12-13 2001-05-29 Ramakrishnan Nagarajan Improvements in or relating to glycopeptide deriveratives
AU647122B2 (en) 1990-05-28 1994-03-17 Gruppo Lepetit S.P.A. C63-amide derivatives of 34-de(acetylglucosaminyl)-34-deoxy- teicoplanin and their use as medicaments against bacteria resistant to glycopeptide antibiotics
WO1992017456A1 (fr) 1991-03-26 1992-10-15 Fujisawa Pharmaceutical Co., Ltd. Derive d'acide amine et sel dudit derive
KR100242682B1 (ko) * 1991-07-29 2000-02-01 클라우디오 쿼르타 항생물질 a 40926의 아미드 유도체
US5750509A (en) 1991-07-29 1998-05-12 Gruppo Lepetit S.P.A. Amide derivatives of antibiotic A 40926
MY128335A (en) 1994-01-28 2007-01-31 Lilly Co Eli Glycopeptide antibiotic derivatives
US5840684A (en) 1994-01-28 1998-11-24 Eli Lilly And Company Glycopeptide antibiotic derivatives
IT1282586B1 (it) 1996-02-08 1998-03-31 Chemical And Biolog Ind Composizioni farmaceutiche per il trattamento biologico delle infezioni dovute a ceppi di enterococcus faecium resistenti agli
EP0934076A1 (en) 1996-03-21 1999-08-11 Intercardia, Inc. Solid phase lipoglycopeptide library, compositions and methods
JP4159110B2 (ja) 1996-04-12 2008-10-01 イーライ・リリー・アンド・カンパニー グリコペプチド化合物
AU2441697A (en) 1996-04-12 1997-11-07 Eli Lilly And Company Covalently-linked glycopeptide dimers
KR20000010589A (ko) 1996-04-23 2000-02-15 클라우디오 쿼르타 항생제a40926의아미드유도체의개선된화학적제조방법
US5919756A (en) * 1996-06-28 1999-07-06 Eli Lilly And Company Amides
US5952466A (en) 1997-11-12 1999-09-14 Eli Lilly And Company Reductive alkylation of glycopeptide antibiotics
US5939382A (en) 1996-11-21 1999-08-17 Eli Lilly And Company Reducing agent for reductive alkylation of glycopeptide antibiotics
US5916873A (en) 1997-04-17 1999-06-29 Eli Lilly And Company Teicoplanin derivatives
US5977063A (en) 1997-05-20 1999-11-02 Eli Lilly And Company Alkylated hexapeptides
US5952310A (en) 1997-05-20 1999-09-14 Eli Lilly And Company Glycopeptide hexapeptides
US5919771A (en) 1997-05-20 1999-07-06 Eli Lilly And Company Urea and thiourea derivatives of glycopeptides
FR2778184A1 (fr) 1998-02-20 1999-11-05 Advanced Medicine Inc Composes a liaisons multiples antibacteriens nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
US6518242B1 (en) 1998-02-20 2003-02-11 Theravance, Inc. Derivatives of glycopeptide antibacterial agents
WO1999056760A1 (en) 1998-05-01 1999-11-11 Eli Lilly And Company N1-modified glycopeptides
NZ509165A (en) 1998-07-14 2003-08-29 Univ Princeton Glycopeptide antobiotics, combinatorial libraries of glycopeptide antibiotics and methods of producing same
DE69908819T2 (de) * 1998-12-23 2004-05-06 Theravance, Inc., South San Francisco Glycopeptid-derivate und pharmazeutische zusammensetzungen, die sie enthalten
UA75083C2 (uk) 2000-06-22 2006-03-15 Тераванс, Інк. Похідні глікопептидфосфонатів
EP1507796B1 (en) 2002-05-24 2012-05-02 Theravance, Inc. Cross-linked glycopeptide-cephalosporin antibiotics
EP1644382B1 (en) 2003-07-11 2008-03-05 Theravance, Inc. Cross-linked glycopeptide-cephalosporin antibiotics

Also Published As

Publication number Publication date
WO2000039156A1 (en) 2000-07-06
DE69908819D1 (de) 2003-07-17
KR20010085857A (ko) 2001-09-07
CN1249081C (zh) 2006-04-05
US20030060598A1 (en) 2003-03-27
US7351791B2 (en) 2008-04-01
US7101964B2 (en) 2006-09-05
ZA200007222B (en) 2002-03-06
BR9914221A (pt) 2001-06-26
PL348451A1 (en) 2002-05-20
CZ200122A3 (en) 2001-06-13
IL140093A (en) 2006-06-11
HUP0400887A3 (en) 2012-09-28
PT1140993E (pt) 2003-10-31
US6444786B1 (en) 2002-09-03
BRPI9914221B8 (pt) 2021-05-25
US6392012B1 (en) 2002-05-21
US20060241024A1 (en) 2006-10-26
AU768204B2 (en) 2003-12-04
US20090215982A1 (en) 2009-08-27
PL198311B1 (pl) 2008-06-30
HU230190B1 (hu) 2015-09-28
HK1040721B (en) 2003-10-17
HUP0400887A2 (hu) 2004-08-30
SI1140993T1 (en) 2003-12-31
DE69908819T2 (de) 2004-05-06
AU3127300A (en) 2000-07-31
US20040204346A1 (en) 2004-10-14
CA2336445A1 (en) 2000-07-06
BR9914221B1 (pt) 2013-12-31
HK1040721A1 (en) 2002-06-21
NO20006323D0 (no) 2000-12-12
NZ508594A (en) 2003-05-30
EP1140993B1 (en) 2003-06-11
US20080103292A1 (en) 2008-05-01
US7723470B2 (en) 2010-05-25
US6962970B2 (en) 2005-11-08
NO20006323L (no) 2001-02-12
ES2201825T3 (es) 2004-03-16
US8030445B2 (en) 2011-10-04
US6949681B2 (en) 2005-09-27
CZ301184B6 (cs) 2009-12-02
US20050239690A1 (en) 2005-10-27
CA2336445C (en) 2011-07-19
IL140093A0 (en) 2002-02-10
CN1315961A (zh) 2001-10-03
US6455669B1 (en) 2002-09-24
ATE242783T1 (de) 2003-06-15
EP1140993A1 (en) 2001-10-10
JP2002533472A (ja) 2002-10-08
JP4362017B2 (ja) 2009-11-11
NO326066B1 (no) 2008-09-08
DK1140993T3 (da) 2003-10-06

Similar Documents

Publication Publication Date Title
KR100665204B1 (ko) 글리코펩티드 유도체 및 그를 포함하는 약학적 조성물
KR100768488B1 (ko) 글리코펩티드 포스포네이트 유도체
JP2003531869A (ja) シクロデキストリンを含むグリコペプチド抗生物質組成物
DE60133198T2 (de) Glykopeptidderivate mit carboxysacchariden
US20030008812A1 (en) Glycopeptide derivatives
WO2001057071A2 (en) Glycopeptide derivatives having antibiotic activity
MXPA01001861A (en) Glycopeptide derivatives and pharmaceutical compositions containing the same

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20010327

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20041122

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20060428

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20061206

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20061228

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20061229

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
PR1001 Payment of annual fee

Payment date: 20091222

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 20101215

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 20111208

Start annual number: 6

End annual number: 6

FPAY Annual fee payment

Payment date: 20121210

Year of fee payment: 7

PR1001 Payment of annual fee

Payment date: 20121210

Start annual number: 7

End annual number: 7

FPAY Annual fee payment

Payment date: 20131211

Year of fee payment: 8

PR1001 Payment of annual fee

Payment date: 20131211

Start annual number: 8

End annual number: 8

FPAY Annual fee payment

Payment date: 20141210

Year of fee payment: 9

PR1001 Payment of annual fee

Payment date: 20141210

Start annual number: 9

End annual number: 9

FPAY Annual fee payment

Payment date: 20151208

Year of fee payment: 10

PR1001 Payment of annual fee

Payment date: 20151208

Start annual number: 10

End annual number: 10

FPAY Annual fee payment

Payment date: 20171213

Year of fee payment: 12

PR1001 Payment of annual fee

Payment date: 20171213

Start annual number: 12

End annual number: 12

FPAY Annual fee payment

Payment date: 20181211

Year of fee payment: 13

PR1001 Payment of annual fee

Payment date: 20181211

Start annual number: 13

End annual number: 13

PC1801 Expiration of term

Termination date: 20200622

Termination category: Expiration of duration